4//SEC Filing
Schwartz Jonathan David 4
Accession 0001140361-25-031762
CIK 0001281895other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 4:35 PM ET
Size
4.9 KB
Accession
0001140361-25-031762
Insider Transaction Report
Form 4
Schwartz Jonathan David
See Remarks
Transactions
- Sale
Common Stock
2025-08-14$3.02/sh−11,161$33,695→ 224,094 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001726398
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 4:35 PM ET
- Size
- 4.9 KB